Á lódáil...
The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...
Na minha lista:
Foilsithe in: | HPB (Oxford) |
---|---|
Main Authors: | , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Elsevier
2016
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/ https://ncbi.nlm.nih.gov/pubmed/27154804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|